Records containing: Prader-Willi Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-09-29Effects of Exenatide on Obesity and Appetite in Overweight Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2016-09-13Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2016-09-09A 5 Treatment Period Crossover Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
-
CLINICAL_TRIALS study record update · 2016-09-01A Dose Titration Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Extension
-
CLINICAL_TRIALS study record update · 2016-08-24Efficacy and Tolerance of Treatment With an Aromatase Inhibitor (Anastrozole) to Limit the Progression of Bone Maturation Related to Pathological Adrenarche in Children With Silver-Russell or Prader-Willi Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-07-18Randomized, Double-Blind, Placebo Controlled, Parallel Dose Ranging Phase 2a Trial of ZGN-440 (Subcutaneous Beloranib in Suspension), A Novel Methionine Aminopeptidase 2 Inhibitor, in Over-weight and Obese Subjects With Prader-Willi Syndrome to Evaluate Weight Reduction, Food-related Behavior, Safety, and Pharmacokinetics Over 4 Weeks Followed by Optional 4-Week Open-Label Extension
-
CLINICAL_TRIALS study record update · 2016-02-02Sleep Abnormalities in Rare Genetic Disorders: Angelman Syndrome, Rett Syndrome, and Prader Willi
-
CLINICAL_TRIALS study record update · 2015-12-16Phase 1 Study of Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2014-09-22Prader-Willi Syndrome and Early-onset Morbid Obesity Natural History Clinical Protocol
-
CLINICAL_TRIALS study record update · 2014-07-24Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children and Young Adults With Prader-Willi Syndrome (PWS): Octreotide Intervention Sub-study
-
CLINICAL_TRIALS study record update · 2013-05-01Topiramate Effects on SIB in Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2012-06-19Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2012-02-01The Intestinal Function in People With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2011-11-24Correlation Between Hyperghrelinemia and Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2011-06-2711 Beta Hydroxysteroid Dehydrogenase 1 (11-beta HSD 1) Activity in Patients With Prader-Willi Syndrome and in Healthy Controls
-
CLINICAL_TRIALS study record update · 2008-12-16ClinicalTrials.gov study NCT00808548
-
CLINICAL_TRIALS study record update · 2008-12-02Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
-
CLINICAL_TRIALS study record update · 2007-10-31Effect of Somatostatin on Ghrelin Concentrations, Food Seeking Behaviour and Weight in Patients With Prader-Willi Syndrome